Avita Medical (ASX: AVH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Avita Medical Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Avita Medical (ASX: AVH)
Latest News
Healthcare Shares
Broker lists one ASX healthcare stock as a buy and one a sell
Healthcare Shares
Guess which ASX All Ords stock is jumping 11% on 'important milestone'
Share Gainers
Guess which ASX All Ords healthcare share is jumping 11% on big European news
Broker Notes
Morgans names 3 ASX shares to buy this week
Healthcare Shares
Guess which ASX All Ords stock just crashed 23% on earnings miss
Share Market News
Why AVITA, Botanix, Brainchip, and NAB shares are falling today
Share Gainers
Guess which ASX All Ords stock just leapt 9% on big US news
Earnings Results
2 ASX All Ords shares soaring on strong full year results
Share Fallers
Why AVITA Medical, Lovisa, Star, and Westgold shares are sinking today
Share Fallers
Why AVITA Medical, Block, Computershare, and GQG Partners shares are falling today
Share Fallers
Why did this ASX All Ords stock just crash 17%?
Share Fallers
Why AVITA Medical, Life360, Newmont, and St Barbara shares are falling today
Frequently Asked Questions
-
No, AVITA Medical does not pay dividends at this time.
-
AVITA Medical Inc listed on the ASX on 24 June 2020.
-
Yes, as well as being listed on the ASX, AVITA Medical Inc is listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
AVH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Avita Medical
AVITA Medical Inc (ASX: AVH) is a healthcare company specialising in regenerative medicine. It is best known for its RECELL system, a burn treatment device that creates 'spray-on skin' from a patient's own skin cells within 30 minutes, avoiding or reducing the need for skin grafts.
The product was originally invented and patented by Western Australian doctor and clinical professor Fiona Wood in 1993.
RECELL is approved for use in Australia, Europe, Canada, China, the Middle East, and Africa. It is also approved for treating adult patients in the US. As well as burns, AVITA Medical has evidence of RECELL's effectiveness for additional skin applications, such as treating chronic and traumatic wounds, scar revision, and vitiligo.
AVITA Medical Inc is domiciled and also listed on the US Nasdaq where it trades under the ticker NASDAQ: RCEL.
